Carmen S. Fonseca
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
FIGNL1 inhibits homologous recombination in BRCA2 deficient cells by dissociating RAD51 filaments.
Journal: Science (New York, N.Y.)
Published: October 30, 2025
EXO1 as a therapeutic target for Fanconi Anaemia, ZRSR2 and BRCA1-A complex deficient cancers.
Journal: Nature communications
Published: June 26, 2024
DNA Combing versus DNA Spreading and the Separation of Sister Chromatids.
Journal: bioRxiv : the preprint server for biology
Published: May 19, 2023
DNA combing versus DNA spreading and the separation of sister chromatids.
Journal: The Journal of cell biology
Published: May 19, 2023
The Effect of Body Fat Distribution on Systemic Sclerosis.
Journal: Journal of clinical medicine
Published: September 16, 2022
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis.
Journal: NPJ genomic medicine
Published: March 03, 2022
Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes.
Journal: Annals of the rheumatic diseases
Published: January 11, 2021
Structure-Activity Relationship Studies of Pyrimidine-4-Carboxamides as Inhibitors of N-Acylphosphatidylethanolamine Phospholipase D.
Journal: Journal of medicinal chemistry
Published: December 31, 2020
Genomic Risk Score impact on susceptibility to systemic sclerosis.
Journal: Annals of the rheumatic diseases
Published: July 08, 2020
Analysis of Anti-RNA Polymerase III Antibody-positive Systemic Sclerosis and Altered GPATCH2L and CTNND2 Expression in Scleroderma Renal Crisis.
Journal: The Journal of rheumatology
Published: February 28, 2020
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways.
Journal: Nature communications
Published: February 28, 2019
Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: February 20, 2019
Last Updated: 09/26/2026